Special Issue

Topic: Role of Oncolytic Viruses in Cancer Therapy
A Special Issue of Journal of Translational Genetics and Genomics
ISSN 2578-5281 (Online)
Submission deadline: 31 May 2021
Guest Editor(s)
Submission Deadline
31 May 2021
Submission Information
For Author Instructions, please refer to https://oaepublish.com/jtgg/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jtgg&SpecialIssueId=554
Submission Deadline: 31 May 2021
Contacts: Ryna Ni, Assistant Editor, Assistant_Editor@jtggjournal.com
Published Articles
Open Access Original Article
Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus
This article belongs to the Special Issue Role of Oncolytic Viruses in Cancer Therapy
J Transl Genet Genom 2021;5:423-42.
Available online: 4 Dec 2021
Open Access Review
Talimogene laherparepvec and novel injectable oncolytic viruses in the management of metastatic melanoma
This article belongs to the Special Issue Role of Oncolytic Viruses in Cancer Therapy
J Transl Genet Genom 2021;5:396-413.
Available online: 4 Nov 2021
Open Access Review
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
This article belongs to the Special Issue Role of Oncolytic Viruses in Cancer Therapy
J Transl Genet Genom 2021;5:304-22.
Available online: 3 Aug 2021